Vistra (VST) traded at $129.61, below its short-term moving averages but still inside a broader analyst target range that now runs from $169 to $198 among the most recent notes cited. The stock is ...
Vistra’s latest catalyst was the November 6 third-quarter 2026 results package, which showed GAAP net income of $1.14 billion and Ongoing Operations adjusted EBITDA of $2.378 billion, more than 50% above the prior-year quarter. Management also lifted the midpoint and narrowed 2026 guidance for adjusted EBITDA to $7.1 billion-$7.5 billion and adjusted FCFbG to $4.3 billion-$4.7 billion, then introduced 2027 ranges of $7.7 billion-$8.5 billion and $4.3 billion-$5.1 billion, respectively. The board also authorized another $1.5 billion of share repurchases, expected to be used by year-end 2028.
That backdrop matters because the stock is not trading as if the operational update has fully reset expectations. At $129.61, VST is still below the 7-day SMA at $131.04, the 20-day SMA at $130.77 and the 12-day EMA at $130.75, while the 50-day SMA sits much higher at $142.25. The near-term setup is therefore more about whether the market can hold the post-earnings base than about chasing momentum straight away.
Recent analyst work is still broadly supportive. BMO Capital maintained Outperform and raised its target to $196 from $188 on November 17, while Sanford C. Bernstein lifted its target to $182 from $181 and kept an Outperform rating. Scotiabank, however, cut its target to $169 from $189 on November 9, citing elevated political and headline risks in Texas while keeping Sector Outperform.
Source link







